Physician profile
Shawn Mathur
NPI 1760828586
$3,112.90
in general payments reported to CMS, 2019-2025
35 companies · $574 in 2025
The $574 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,188 · 2020: $56.97 · 2021: $80.42 · 2022: $202 · 2023: $199 · 2024: $812 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.19 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $956.20 | 2019-2025 | Watchman Flx, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Sumitomo Pharma America, INC. | $259.73 | 2023-2025 | Gemtesa |
| Procept Biorobotics Corporation | $244.78 | 2022-2025 | Aquabeam System |
| Impulse Dynamics (USA) INC. | $174.10 | 2024 | Optimizer |
| Endo Pharmaceuticals INC. | $141.64 | 2019-2022 | |
| 180 Medical, INC. | $121.74 | 2022-2024 | Cure Catheter, Gentlecath |
| Janssen Pharmaceuticals, INC | $111.29 | 2019-2024 | Xarelto |
| Medtronic, INC. | $102.12 | 2021-2025 | Interstim, Inceptiv |
| Astellas Pharma US INC | $90.38 | 2019-2023 | Myrbetriq |
| Progenics Pharmaceuticals, INC. | $85.56 | 2024-2025 | |
| Tolmar, INC. | $71.69 | 2025 | Jatenzo, Eligard |
| Convatec INC. | $61.90 | 2019-2025 | |
| Neotract INC. | $61.71 | 2019 | |
| Agiliti Surgical, INC. | $61.13 | 2024 | Koelis Trinity Fusion Biopsy System, Soltive Superpulsed Laser, Sonablate Hifu |
| Abbott Laboratories | $59.35 | 2023-2024 | Cardiomems, Proclaim |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $47.08 | 2025 | Xiaflex, Aveed |
| Novo Nordisk INC | $45.00 | 2019 | |
| Karl Storz Endoscopy-America | $38.32 | 2021 | |
| Janssen Biotech, INC. | $35.26 | 2019 | |
| Bard Peripheral Vascular, INC. | $33.94 | 2020 | |
| Olympus America INC. | $32.36 | 2020-2024 | Itind System |
| Abbvie INC. | $29.01 | 2024 | |
| Laborie Medical Technologies Corp. | $27.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Lilly USA, LLC | $26.36 | 2022 | |
| Axsome Therapeutics, INC. | $24.74 | 2022 | |
| Urogen Pharma, INC. | $22.04 | 2023 | Jelmyto |
| Shire North American Group INC | $21.94 | 2019 | |
| Inspire Medical Systems, INC. | $19.74 | 2025 | Inspire |
| Abiomed | $17.35 | 2025 | |
| Civco Medical Instruments | $17.05 | 2024 | |
| Teleflex LLC | $16.32 | 2024 | Urolift |
| Pulmonx Corporation | $15.61 | 2023 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Coloplast Corp | $14.51 | 2019 | |
| Exact Sciences Corporation | $13.79 | 2023 | Cologuard Collection Kit |
| Cequr Corporation | $12.10 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.